ERVIN GRAVES STRATEGY GROUP, LLC

Lobbying for AMERICAN MEDICINES COMPANY · Manufacturer of Generic Medication

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $30,000.00 income · posted Jan 19, 2026

Lobbying activity 1

Health Issues

Appropriations/Funding and Support for strengthening the domestic supply chain for generic medication manufacturing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.